5 Things Regeneron (REGN)'s CEO Said As The Biotech Stock Sank  
9/12/2017 6:41:05 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Regeneron (NASDAQ:REGN) CEO Leonard Schleifer was on the hot seat Monday at the Morgan Stanley healthcare conference. And the timing was either terrific or terrible, depending on your perspective. Regeneron stock opened more than 4% below its previous close, and things got worse during intraday trading.